Page 775 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition

CHAPTER 33 Hematopoietic Tumors 753

37. Waugh EM, Gallagher A, McAulay KA, et al.: Gammaherpesvi- 58. Schmiedt CW, Grimes JA, Holzman G, et al.: Incidence and risk
ruses and canine lymphoma: no evidence for direct involvement factors for development of malignant neoplasia after feline renal
in commonly occurring lymphomas, J Gen Virol 96:1863–1872, transplantation and cyclosporine-based immunosuppression, Vet
VetBooks.ir 38. Milman G, Smith KC, Erles K: Serological detection of Epstein- 59. Santoro D, Marsella R, Hernandez J: Investigation on the asso-
Comp Oncol 7:45–53, 2009.
2015.
Barr virus infection in dogs and cats, Vet Microbiol 150:15–20,
2011. ciation between atopic dermatitis and the development of mycosis
fungoides in dogs: a retrospective case-control study, Vet Dermatol
39. Farinha P, Gascoyne RD: Helicobacter pylori and MALT lym- 18:101–106, 2007.
phoma, Gastroenterology 128:1579–1605, 2005. 60. Madewell B: Hematopoietic neoplasms, sarcomas and related con-
40. Rossi G, Rossi M, Vitali CG, et al.: A conventional beagle dog ditions. In Theilen GH, Madewell B, editors: Veterinary Cancer
model for acute and chronic infection with Helicobacter pylori, Medicine, ed 2, Philadelphia, 1987, Lea and Febiger.
Infect Immun 67:3112–3120, 1999. 61. Couto CG, Rutgers HC, Sherding RG, et al.: Gastrointestinal
41. Gavazza A, Rossi G, Lubas G, et al.: Faecal microbiota in dogs with lymphoma in 20 dogs. A retrospective study, J Vet Intern Med
multicentric lymphoma, Vet Comp Oncol, 2017. 1989(3):73–78, 1989.
42. Ruple A, Avery AC, Morley PS: Differences in the geographic dis- 62. Ozaki K, Yamagami T, Nomura K, et al.: T-cell lymphoma with
tribution of lymphoma subtypes in Golden retrievers in the USA, eosinophilic infiltration involving the intestinal tract in 11 dogs,
Vet Comp Oncol 15:1590–1597, 2017. Vet Pathol 43:339–344, 2006.
43. Takashima-Uebelhoer BB, Barber LG, Zagarins SE, et al.: House- 63. Breitschwerdt EB, Waltman C, Hagstad HV, et al.: Clinical and
hold chemical exposures and the risk of canine malignant lym- epidemiologic characterization of a diarrheal syndrome in Basenji
phoma, a model for human non-Hodgkin’s lymphoma, Environ dogs, J Am Vet Med Assoc 180:914–920, 1982.
Res 112:171–176, 2012. 64. Couto KM, Moore PF, Zwingenberger AL, et al.: Clinical char-
44. Hayes HM, Tarone RE, Cantor KP, et al.: Case-control study of acteristics and outcome in dogs with small cell T-cell intestinal lym-
canine malignant lymphoma: positive association with dog owner’s phoma, Vet Comp Oncol, 2018. https://doi.org/10.1111/vco.12384.
use of 2,4-dichlorophenoxyacetic acid herbicides, J Natl Cancer Inst epub ahead of print.
83:1226–1231, 1991. 65. Coyle KA, Steinberg H: Characterization of lymphocytes in canine
45. Reynolds PM, Reif JS, Ramsdell HS, et al.: Canine exposure to gastrointestinal lymphoma, Vet Pathol 41:141–146, 2004.
herbicide-treated lawns and urinary excretion of 2,4-dichlorophen- 66. Steinberg H, Dubielzig RR, Thomson J, et al.: Primary gastrointes-
oxyacetic acid, Cancer Epidemiol Biomarkers Prev 3:233–237, 1994. tinal lymphosarcoma with epitheliotropism in three Shar-pei and
46. Carlo GL, Cole P, Miller AB, et al.: Review of a study reporting one boxer dog, Vet Pathol 32:423–426, 1995.
an association between 2,4-dichlorophenoxyacetic acid and canine 67. Rosenberg MP, Matus RE, Patnaik AK: Prognostic factors in dogs
malignant lymphoma: report of an expert panel, Regul Toxicol Phar- with lymphoma and associated hypercalcemia, J Vet Intern Med
macol 16:245–252, 1992. 5:268–271, 1991.
47. Garabrant DH, Philbert MA: Review of 2,4-dichlorophenoxy- 68. Vail DM, Kisseberth WC, Obradovich JE, et al.: Assessment of
acetic acid (2,4-D) epidemiology and toxicology, Crit Rev Toxicol potential doubling time (Tpot), argyrophilic nucleolar organizer
32:233–257, 2002. regions (AgNOR), and proliferating cell nuclear antigen (PCNA)
48. Kaneene JB, Miller R: Re-analysis of 2,4-D use and the occurrence as predictors of therapy response in canine non-Hodgkin’s lym-
of canine malignant lymphoma, Vet Hum Toxicol 41:164–170, phoma, Exp Hematol 24:807–815, 1996.
1999. 69. Ruslander DA, Gebhard DH, Tompkins MB, et al.: Immunophe-
49. Gavazza A, Presciuttini S, Barale R, et al.: Association between notypic characterization of canine lymphoproliferative disorders,
canine malignant lymphoma, living in industrial areas, and use of Vivo 11:169–172, 1997.
chemicals by dog owners, J Vet Intern Med 15:190–195, 2001. 70. Ortiz AL, Carvalho S, Leo C, et al.: Gamma delta T-cell large gran-
50. Reif JS, Lower KS, Ogilvie GK: Residential exposure to magnetic ular lymphocyte lymphoma in a dog, Vet Clin Pathol 44:442–447,
fields and risk of canine lymphoma, Am J Epidemiol 141:352–359, 2015.
1995. 71. Moore PF, Affolter VK, Keller SM: Canine inflamed nonepithelio-
51. Marconato L, Leo C, Girelli R, et al.: Association between waste tropic cutaneous T-cell lymphoma: a diagnostic conundrum, Vet
management and cancer in companion animals, J Vet Intern Med Dermatol 24:204–211, e244–205, 2013.
23:564–569, 2009. 72. Gross T, Ihrke PJ, Walder EJ, et al.: Lymphocytic neoplasms. In
52. Pastor M, Chalvet-Monfray K, Marchal T, et al.: Genetic and envi- Gross TL, Ihrke PJ, Walder EJ, et al.: Skin diseases of the dog and cat,
ronmental risk indicators in canine non-Hodgkin’s lymphomas: ed 2, Oxford, 2005, Blackwell, pp 866–893.
breed associations and geographic distribution of 608 cases diag- 73. Broder S, Muul L, Marshall S, et al.: Neoplasms of immunoregula-
nosed throughout France over 1 year, J Vet Intern Med 23:301–310, tory T cells in clinical investigation, J Invest Dermatol 74:267–271,
2009. 1980.
53. Pinello KC, Santos M, Leite-Martins L, et al.: Immunocytochemi- 74. Fontaine J, Heimann M, Day MJ: Canine cutaneous epitheliotro-
cal study of canine lymphomas and its correlation with exposure to pic T-cell lymphoma: a review of 30 cases, Vet Dermatol 21:267–
tobacco smoke, Vet World 10:1307–1313, 2017. 275, 2010.
54. Keller ET: Immune-mediated disease as a risk factor for canine 75. Moore PF, Affolter VK, Graham PS, et al.: Canine epitheliotro-
lymphoma, Cancer 70:2334–2337, 1992. pic cutaneous T-cell lymphoma: an investigation of T-cell receptor
55. Foster AP, Sturgess CP, Gould DJ, et al.: Pemphigus foliaceus in immunophenotype, lesion topography and molecular clonality, Vet
association with systemic lupus erythematosus, and subsequent Dermatol 20:569–576, 2009.
lymphoma in a cocker spaniel, J Small Anim Pract 41:266–270, 76. Moore PF, Olivry T, Naydan D: Canine cutaneous epitheliotropic
2000. lymphoma (mycosis fungoides) is a proliferative disorder of CD8+
56. Aronson LR: Update on the current status of kidney transplanta- T cells, Am J Pathol 144:421–429, 1994.
tion for chronic kidney disease in animals, Vet Clin North Am Small 77. Affolter VK, Gross TL, Moore PF: Indolent cutaneous T-cell lym-
Anim Pract 46:1193–1218, 2016. phoma presenting as cutaneous lymphocytosis in dogs, Vet Derma-
57. Blackwood L, German AJ, Stell AJ, et al.: Multicentric lymphoma tol 20:577–585, 2009.
in a dog after cyclosporine therapy, J Small Anim Pract 45:259–262, 78. Foster AP, Evans E, Kerlin RL, et al.: Cutaneous T-cell lymphoma
2004. with Sezary syndrome in a dog, Vet Clin Pathol 26:188–192, 1997.